Order:
  1.  10
    Pharmaceutical Ethics and Grassroots Activism in the United States: A Social History Perspective.Sharon Batt, Judy Butler, Olivia Shannon & Adriane Fugh-Berman - 2020 - Journal of Bioethical Inquiry 17 (1):49-60.
    Women’s health activists laid the groundwork for passage of the law that created the U.S. Food and Drug Administration in 1906. The pharmaceutical and food industries fought regulatory reforms then and continue to do so now. We examine public health activism in the Progressive Era, the postwar era and the present day. The women’s health movement began in the 1960s, and criticized both the pharmaceutical industry and the medical establishment. In the 1990s, patient advocacy groups began accepting industry funds; thousands (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  2.  15
    Limits on Autonomy: Political Meta-Narratives and Health Stories in the Media.Sharon Batt - 2007 - American Journal of Bioethics 7 (8):23 – 25.
  3.  45
    Pharmaceutical Company Corruption and the Moral Crisis in Medicine.Sharon Batt - 2016 - Hastings Center Report 46 (4):10-13.
    A much-debated series of articles in the New England Journal of Medicine in May 2015 labeled the pharmaceutical industry's critics “pharmascolds.” Having followed the debate for two decades, I count myself among the scolds. The weight of the evidence overwhelmingly supports the claim that pharmaceutical policy no longer serves the public interest; the central questions now are how this happened and what to do about it. I approached three of the most recent books on the industry with these questions in (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  4.  2
    Unhealthy Partnerships and Public Health: Breaking Free of Industry.Sharon Batt - 2019 - Hastings Center Report 49 (6):39-40.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark